2D |
2- Dimensional |
3D |
3- Dimensional |
AKT |
Protein kinase B |
AMPK |
5′ Adenosine monophosphate - activated protein kinase |
ATP |
Adenosine triphosphate |
BGP-15 |
Poly (adenosine 5′-diphosphate)–ribose] polymerase 1 (PARP-1) Inhibitor |
CIM |
Critical illness myopathy |
CIP |
Critical illness polyneuropathy |
CK |
Creatine kinase |
CMAP |
Compound muscle action potential |
COVID-19 |
Coronavirus disease 2019 |
CSA |
Cross sectional area |
FBOX31, |
F-box only protein 31 |
FDA |
Food and drug administration |
GCaMP6 |
Genetically encoded calcium indicator |
GDF-15 |
Growth and differentiation factor 15 |
HSP |
Heat shock protein |
ICU |
Intensive care unit |
ICUAW |
ICU - acquired weakness |
IF4E- binding protein 1 |
Eukaryotic translation initiation factor 4E binding protein 1 |
IGF1 |
Insulin-like growth factor -1 |
IL-1 |
Interleukin-1 |
IL-6 |
Interleukin-6 |
LC3 -I/II |
Microtubule-associated protein light chain 3 (I/II) |
MAFbx |
Muscle-atrophy F box protein |
MAPK |
Mitogen-activated protein kinase |
MRC |
Medical research council |
mRNA |
Messenger RNA |
mTOR |
Mammalian target of rapamycin |
mTORC1 |
Mammalian target of rapamycin complex 1 |
mTORC2 |
Mammalian target of rapamycin complex 2 |
MuRF1 |
Muscle ring finger protein 1 |
MuRF2 |
Muscle ring finger protein 2 |
MV |
Mechanical ventilation |
MyHC |
Myosin heavy chain |
NF-kB |
Nuclear factor-κB |
NMBA |
Neuromuscular blocking agent |
PGC-1 |
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
PI3K |
Phosphoinositide 3-kinase |
RNA |
Ribonucleic acid |
RyR |
Ryanodine receptors |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
SERCA |
Sarco/endoplasmic reticulum Ca2+ -ATPase |
TEAD1 |
TEA domain transcription factor 1 |
TFAM |
Mitochondrial transcription factor A |
TGFβ |
Transforming growth factor β |
TNFα |
Tumor necrosis factor α |
TRIM32 |
Tripartite motif-containing protein 32 |
UNC-45B |
Unc-45 myosin chaperone B |
UPS |
Ubiquitin proteasome system |
UTR |
Untranslated region |